// App-Quantinova.ai

P23 : Adult onset Still’s disease as a novel autoimmune complication of alemtuzumab therapy: a case report and review of alemtuzumab associated autoimmune disease

Researchers

Presenter

  • Nehal Narayan

Principal Investigators

  • Gordon Mazibrada

  • Nicole Amft

Medical Centers

  • Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK

  • Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Adult onset Still's disease

Biomarkers

  • N/A

Drug/Treatment

  • Alemtuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved